reported side effects of adalimumab
upper respiratory tract infection
headache
injection site reaction
skin rash
antibody development
sinusitis
pain at injection site
other side effects
urinary tract infection
abdominal pain
flu-like symptoms
comprehensive list of adverse effects
serious adverse reactions
been serious infections
neurologic events
malignancies
accidental injury
pain in extremity
thorax painrare
pyrexiafrequency
sepsis
pain in thorax
opportunistic infections
tuberculosis
histoplasmosis
abscess
joint infection
wound infection
superficial fungal infections
tuberculosis cases
first months of therapy
pulmonary types
opportunistic infections
histoplasma
aspergillus
nocardia
headache uncommon
confusion
paresthesia
subdural hematoma
tremor
demyelinating disorders
optic neuritis
guillain-barre syndrome
cerebrovascular accident
multiple sclerosis
hypertrophic pachymeningitis
adenoma
merkel cell carcinoma
neuroendocrine carcinoma of the skin
skin papilloma
carcinomas
breast
skin
lymphoma
melanoma
cancer of the white blood cells
hepatosplenic t-cell lymphoma
hstcl
adolescents
young adults
controlled portions of adalimumab trials in patients
active rheumatoid arthritis
psoriatic arthritis
ankylosing spondylitis
malignancies
lymphoma
non-melanoma skin cancer
rate
patient-years among adalimumab-treated patients
rate
patient-years among control patients
median duration of treatment
months for adalimumab-treated patients
months for control-treated patients
controlled portions of adalimumab rheumatoid arthritis trials
rate of non-melanoma skin cancers
patient-years among adalimumab-treated patients
patient-years among control patients
cases of malignancies
patients
receiving tnf blockers
including adalimumab
controls
patients with rheumatoid arthritis
active disease
higher risk for the development of lymphoma
meta-analysis
dose-dependent increased risk of malignancies in patients with rheumatoid arthritis
anti-tnf antibody therapy
positive ana titers
week
patients
placebo
patient
symptoms of new-onset
lupus-like syndrome
discontinuation of adalimumab
low-titer antibodies
adalimumab
treatment
patients
n =-rrb-
antibodies
patients on adalimumab monotherapy
patients on concurrent methotrexate
monotherapy
acr
american college of rheumatology criteria
response
antibody-positive patients
meta-analysis
evidence of an
increased risk of serious infections in patients with rheumatoid arthritis
anti-tnf antibody therapy
flu syndromeuncommon
sarcoidosisfrequency
development of autoantibodies
painuncommon
arthritis
bone disorder
bone fracture
bone necrosis
joint disorder
muscle cramps
myasthenia
pyogenic arthritis
synovitis
tendon disorder
pelvic painrare
rhabdomyolysis
upper
respiratory infection
sinusitis
pneumonia
pharyngitis
nasopharyngitisuncommon
asthma
bronchospasm
dyspnea
lung function
pleural effusion
interstitial lung disease
including
pulmonary fibrosis
pulmonary embolismfrequency
cough
upper respiratory infection
pharyngeal edema
nasal congestion
pulmonary edema
pleural effusion
pleurisy
diarrhea
nausea
abdominal pain
vomiting
stomatitis
mouth ulcerationuncommon
cholecystitis
cholelithiasis
gastroenteritis
gastrointestinal hemorrhage
gastritis
dyspepsia
gastrointestinal disorder
gastrointestinal hemorrhage
rectal hemorrhage
abdominal bloatingrare
esophagitis
intestinal stenosis
colitis
enteritisfrequency
diverticulitis
large bowel perforations
perforations
diverticulitis
appendiceal perforations
appendicitis
pancreatitis
hypercholesterolemia
hyperlipidemiauncommon
dehydration
ketosis
paraproteinemia
alkaline phosphatase
paraproteinemia
urinary tract infection
hematuriauncommon
cystitis
kidney calculus
menstrual disorder
pyelonephritis
injection site pain
injection site reaction
rash common
dermatitis
eczema
pruritus
cellulitis
urticaria
psoriasis
ecchymosis
purpura
erysipelas
cutaneous vasculitis
herpes zosterpostmarketing reports
stevens johnson syndrome
cutaneous vasculitis
erythema multiforme
worsening psoriasis
subtypes
palmoplantar
alopecia
erythema multiforme
panniculitis
cases
worsening
worsening congestive heart failure
chf
new onset chf
tnf blockers
including adalimumab
clinical studies of another tnf blocker
higher rate of serious chf-related adverse events
hypertensionuncommon
arrhythmia
atrial fibrillation
chest pain
coronary artery disorder
heart arrest
hypertensive encephalopathy
myocardial infarct
palpitation
pericardial effusion
pericarditis
syncope
tachycardia
congestive heart failure
peripheral edema
systemic vasculitis
deep vein thrombosisrare
vascular occlusion
aortic stenosis
thrombophlebitis
aortic aneurysm
parathyroid disorder
lymphopenia
agranulocytosis
granulocytopenia
leucopenia
thrombocytopenia
anemia
lymphadenopathy
leucocytosis rare
pancytopenia
polycythemia
idiopathic thrombocytopenia purpura
lymphoma-like reaction
leg thrombosis
hypertriglyceridemia
cataract
frequency
anaphylaxis
liver failure
hepatitisrare
hepatic enzymes
hepatic necrosispostmarketing reports
hepatic failure
frequency
renal pain
renal impairment
stomach fullness
body aches
pain
cough or hoarseness
ear congestion
gas with abdominal
stomach pain
lightheadedness
loss of voice
side pain
muscle aches
pains
nasal congestion
pain
tenderness around the eyes
cheekbones
shallow breathing
shivering
sunken eyes
thirst
trouble sleeping
warmth on the skin
wrinkled skin
stomach pain
abnormal vaginal bleeding
discharge
agitation
arm
jaw pain
black, tarry stools
bleeding from the gums
nose
blindness
bloating
swelling of the face
arms
hands
lower legs
feet
blood in the stool
change in bowel habits
cloudy urine
blurred vision
broken bones
change in size
shape
color of an
existing mole
change in skin color
chest pain
chest tightness
heaviness
chills
bloody discharge from the nipple
cold hands
feet
confusion
constipation
cough
coughing
spitting
blood
decreased urination
decreased vision
depression
frequent urination
difficulty with breathing
difficulty
burning
painful urination
dimpling of the breast skin
dizziness
drowsiness
eye pain
fainting
irregular heartbeat
fever
forgetfulness
frequent urge
general feeling of illness
hair loss
hallucinations
headache
increased thirst
inverted nipple
irregular breathing
irregular pulse
irritability
itching or rash
light colored stools
loss of appetite
lump in the breast
arm
lump
swelling in the abdomen
stomach
mole that leaks fluid
bleeds
muscle cramps
spasms
nausea
new mole
night sweats
blood pressure
pulse
noisy breathing
numbness
tingling
arms
legs
face
pain
redness
swelling in the arms
legs without any injury
pale skin
skin
pink growth
puffiness
swelling of the eyelids
eyes
face
lips
tongue
firm
bright red patch
redness
swelling of the breast
seizures
sharp back pain
ribs
shiny bump
skin
slurred speech
problems
swallowing
sneezing
skin of the breast
sore throat
sores
ulcers
white spots on the lips
mouth
spitting up blood
stiff neck
stopping of the heart
sudden high fever
low grade fever for months
sweating
swelling of the face
fingers
feet
lower legs
swollen glands
swollen neck veins
tightness in the chest
tiredness
trouble breathing with activity
trouble thinking
unconsciousness
unexplained bruising
bleeding
unpleasant breath odor
unusual tiredness
weakness
unusual weight gain
loss
visual disturbances
vomiting
vomiting of blood
material
coffee grounds
yellow skin
eyes
blistering
peeling
loosening of the skin
diarrhea
muscle pain
red spots on the skin
red skin lesions
purple center
red, irritated eyes
scaling
crusted skin
unusual bleeding
bruising
bladder pain
bleeding
burning
coldness
discoloration of the skin
feeling of pressure
general feeling of discomfort
illness
hives
lumps
numbness
pounding in the ears
redness
scarring
soreness
stinging
swelling
tenderness
tingling
ulceration
warmth
abnormal healing
decrease in height
difficulty with moving
difficulty with swallowing
difficulty with walking
dry mouth
heartburn
indigestion
loss of hearing
loss of strength
energy
menstrual changes
muscle
joint stiffness
tightness
rigidity
muscle pain
weakness
pain in the
ribs
arms
legs
shakiness in the legs
arms
hands
feet
sores
stomach pain
fullness
discomfort
swelling
redness in the joints
weakness